Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchIndependent Academic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

CH TAC LLC

United States
1 Trial

CH TAC LLC (Cluster Headache-Trigeminal Autonomic Cephalalgia, LLC) is a US non-profit research entity that co-sponsored Yale University's Phase 1 psilocybin trials for episodic and chronic cluster headache, in partnership with Heffter Research Institute and Ceruvia Lifesciences.

Academic Research

0 papers

Published Papers

0

Trial Involvement

1

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

1
CompletedI

Psilocybin for the Treatment of Cluster Headache

Start Date
Compounds
Psilocybin, Placebo